Streetbeat News

Partnerships

BNRG

Brenmiller Energy (NASDAQ:BNRG) has signed a contract with Tempo, partially owned by Heineken International, to replace the beverage manufacturer's heavy fuel oil boilers at its plant in Netanya, Israel, with Brenmiller's bGen™ ZERO thermal energy storage system. The system will produce sustainable process steam using solar photovoltaic energy and off-peak grid power. Brenmiller estimates that the project will eliminate the use of approximately 2,000 tons of heavy fuel oil annually and mitigate over 6,200 tons of carbon emissions each year. The project is expected to be completed by the end of 2024.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 12:07 pm

BAH

Booz Allen Hamilton (NYSE:BAH) has announced new insights from its AI portfolio, doubling down on its role in deploying AI for the federal government. The firm has been recognized as the largest provider of AI-related services to the federal government. It has scaled its AI portfolio to offer new, specialized AI technology stacks. The firm has nearly 200 active AI projects across defense, national security, and civil missions.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 12:05 pm

GE

SOFIE Biosciences and GE HealthCare have entered into a global licensing agreement for the development and commercialization of SOFIE's two investigational radiopharmaceutical diagnostics. GE HealthCare will take on global rights for [68Ga]FAPI-46 and outside-US rights for [18F]FAPI-74, both currently in Phase II clinical trials. SOFIE will maintain clinical development and commercialization rights for [18F]FAPI-74 in the U.S.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 12:02 pm

LCTX

Lineage Cell Therapeutics, Inc. (LCTX) has been granted a U.S. patent for its proprietary manufacturing and differentiation process for retinal pigmented epithelial cells. The patent, which is exclusively licensed to Lineage, is expected to expire on July 28, 2036. The patented process is used in the development of RG6501 (OpRegen®), a treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD). The program is being developed in collaboration with Roche and Genentech.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 12:01 pm

BCS

BLK

JPM

JPMorgan Chase & Co. has initiated collateral settlement for clients using its Tokenized Collateral Network (TCN), a blockchain-based system. BlackRock Inc. used TCN to convert shares from one of its money market funds into digital tokens, which were then transferred to Barclays PLC for collateral in an over-the-counter derivatives trade. JPMorgan also operates a system called JPM Coin, which facilitates wholesale clients to execute payments denominated in dollars and euros via a blockchain network.

Portfolio Pulse from Nabaparna Bhattacharya

October 11, 2023 | 11:46 am

IQV

IQVIA and CEPI have partnered to enhance global research preparedness for vaccines and other biological countermeasures against emerging infectious diseases. CEPI will utilize IQVIA's clinical research expertise and innovative solutions to strengthen pandemic preparedness in Low- and Middle-Income Countries (LMICs) and accelerate vaccine development.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 11:38 am

COEP

Coeptis Therapeutics has expanded its exclusive license agreement with the University of Pittsburgh to include the SNAP-CAR technology platform in natural killer cells. This builds upon the original agreement for SNAP-CAR T-Cell, a platform designed to target multiple antigens simultaneously and potentially address a range of hematologic and solid tumors, including HER2-expressing cancer.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 11:37 am

PLL

Piedmont Lithium has partnered with Vinland Lithium to advance the Killick Lithium Project in Newfoundland. The partnership aims to explore and develop lithium resources in the region.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 11:36 am

DERM

GNSS

NTWK

SPWH

Insiders at four companies, Genasys Inc. (GNSS), NetSol Technologies, Inc. (NTWK), Sportsman's Warehouse Holdings, Inc. (SPWH), and Journey Medical Corporation (DERM), have recently purchased shares, indicating their confidence in the companies' prospects. Genasys announced a $1 million contract with the U.S. Army, while NetSol reported a decrease in fourth-quarter EPS results and issued FY24 revenue guidance. Sportsman's Warehouse reported worse-than-expected second-quarter earnings, and Journey Medical entered into an exclusive license agreement with Maruho Co., Ltd.

Portfolio Pulse from Lisa Levin

October 11, 2023 | 11:27 am

HMC

MSBHF

Honda Motor and Mitsubishi Corp are planning to collaborate on electricity infrastructure using electric vehicles (EVs), according to a report by Nikkei cited by Reuters.

Portfolio Pulse from Charles Gross

October 11, 2023 | 11:10 am